Silence Therapeutics Plc - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Silence Therapeutics Plc. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Silence Therapeutics Plc. The Group's principal activity is researching and developing pharmaceutical products. It focuses on Ribonucleic Acid Interference technology, as it can selectively silence genes linked to the onset of disease, thus leading to the creation of a new class of therapeutic products. The Group is developing two products relating to Age-Related Macular Degeneration and Acute Kidney Injury. The Group operates in the United Kingdom.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report